

A provider's guide to helping patients afford Tirosint. Covers copay cards, patient assistance, generic alternatives, and cost conversation strategies.
As a prescriber, you already know that Tirosint offers real clinical advantages for certain hypothyroid patients — particularly those with absorption issues, GI conditions, or sensitivities to the fillers and dyes in standard Levothyroxine tablets. But you also know what happens next: the patient goes to the pharmacy, sees the price, and either doesn't fill the prescription or switches to a cheaper alternative without telling you.
Tirosint's cash price of $150 to $250 per month creates a significant adherence barrier. When patients can get generic Levothyroxine tablets for $4 to $20, the cost differential demands a conversation. This guide gives you the tools to have that conversation effectively and connect patients with every available savings option.
Here's the current cost landscape for Tirosint in 2026:
Coverage varies significantly by plan:
The result: even insured patients may face meaningful out-of-pocket costs for Tirosint, and the prior authorization process itself can cause treatment delays.
IBSA Pharma offers several programs that can substantially reduce patient costs:
This is the easiest win for most commercially insured patients. Consider keeping printable savings cards in your office or including the enrollment link in your after-visit summary.
At $65/month, this program undercuts many insurance copays and eliminates the pharmacy stock uncertainty that can disrupt adherence. For patients who have had difficulty finding Tirosint in stock, this also solves the availability problem.
If you have patients who simply cannot afford Tirosint at any price, this program should be your first recommendation. Your staff can help patients start the application process during their office visit.
Beyond manufacturer programs, third-party coupon services can help reduce costs:
These tools are most useful for cash-paying patients who don't qualify for the manufacturer savings card or PAP. They can also be useful when combined with the Tirosint Direct Program as a price-comparison reference.
For a comprehensive patient-facing guide, direct patients to our article on how to save money on Tirosint.
When cost is the primary barrier and the patient doesn't have a clinical need for Tirosint's specific formulation, consider these alternatives:
YARAL Pharma (formerly Lannett) manufactures an authorized generic of Tirosint — Levothyroxine Sodium capsules with the same gel capsule formulation. This may offer a lower price point while maintaining the absorption advantages of the capsule form. Availability may vary.
At $4-$20 per month, generic Levothyroxine tablets (from Mylan, Sandoz, Lannett, and others) are the most cost-effective option. For the majority of hypothyroid patients, these tablets work well. The trade-off: multiple inactive ingredients, potential variability between manufacturers, and absorption that may be affected by food, coffee, and GI conditions.
Some patients have clear clinical reasons to remain on Tirosint despite the cost:
For these patients, the cost conversation should focus on manufacturer programs and the Tirosint Direct Program rather than therapeutic substitution.
The most effective way to prevent cost-related non-adherence is to address it proactively:
Tirosint serves an important clinical niche, but its price can undermine the adherence it's meant to support. By proactively discussing cost, connecting patients with manufacturer savings programs, and knowing when therapeutic alternatives are appropriate, you can help ensure that the patients who need Tirosint can actually afford to take it consistently.
For tools to help your patients find Tirosint in stock, visit Medfinder for Providers. For a complete guide to helping patients find Tirosint, see our provider resource guide.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.